Literature DB >> 30833839

Catastrophic Antiphospholipid Syndrome Presenting as Congestive Heart Failure in a Patient with Thrombotic Microangiopathy.

Iulia M Tulai, Oana M Penciu, Raymond Raut, Alla Rudinskaya.   

Abstract

Thrombotic microangiopathic syndromes are characterized by thrombus formation leading to microangiopathic hemolytic anemia, thrombocytopenia, and end-organ injury that most often affects the kidney and brain. Patients with thrombotic microangiopathy can also present with cardiac involvement, which has been shown to worsen their prognosis. We describe the case of a 46-year-old woman who presented with acute congestive heart failure as a manifestation of catastrophic antiphospholipid syndrome, which is characterized by rapidly progressing multiorgan involvement. Targeted therapy improved our patient's cardiomyopathy and saved her life. Increased recognition of thrombotic microangiopathy as an underlying pathophysiologic mechanism in heart failure and initiation of timely treatment may help to prevent death in patients with thrombotic microangiopathy.

Entities:  

Keywords:  Acute disease; cytomegalovirus infections/complications; heart failure/diagnosis/etiology; lupus erythematosus, systemic/complications/pathology; thrombotic microangiopathies/diagnosis/etiology; treatment outcome

Mesh:

Year:  2019        PMID: 30833839      PMCID: PMC6379002          DOI: 10.14503/THIJ-17-6472

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  8 in total

1.  Incidence and prognosis of acute heart failure in the thrombotic microangiopathies.

Authors:  Apoor S Gami; Suzanne R Hayman; Joseph P Grande; Vesna D Garovic
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

Review 2.  Cardiovascular involvement in systemic lupus erythematosus.

Authors:  B F Mandell
Journal:  Semin Arthritis Rheum       Date:  1987-11       Impact factor: 5.532

Review 3.  Syndromes of thrombotic microangiopathy.

Authors:  James N George; Carla M Nester
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

4.  Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13.

Authors:  C Hughes; J R McEwan; I Longair; S Hughes; H Cohen; S Machin; M Scully
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

Review 5.  Cardiovascular manifestations of systemic lupus erythematosus.

Authors:  N E Doherty; R J Siegel
Journal:  Am Heart J       Date:  1985-12       Impact factor: 4.749

6.  [Cytomegalovirus associated diseases of the heart].

Authors:  U Schönian; B Maisch
Journal:  Herz       Date:  1992-04       Impact factor: 1.443

7.  Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.

Authors:  A Elisabeth Hak; Elizabeth W Karlson; Diane Feskanich; Meir J Stampfer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-10-15

8.  Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected].

Authors:  M Apte; G McGwin; L M Vilá; R A Kaslow; G S Alarcón; J D Reveille
Journal:  Rheumatology (Oxford)       Date:  2008-02-04       Impact factor: 7.580

  8 in total
  2 in total

1.  Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review.

Authors:  Melody Hermel; David Hermel; Saif Azam; Jerold Shinbane; Annahita Sarcon; Erika Jones; Arjun Mehta; Luanda Grazette; Howard Liebman; Ilene Weitz
Journal:  EJHaem       Date:  2020-07-31

2.  Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.

Authors:  Enrico Ammirati; Emanuele Bizzi; Giacomo Veronese; Matthieu Groh; Caroline M Van de Heyning; Jukka Lehtonen; Marc Pineton de Chambrun; Alberto Cereda; Chiara Picchi; Lucia Trotta; Javid J Moslehi; Antonio Brucato
Journal:  Front Med (Lausanne)       Date:  2022-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.